|
Name |
19-O-methyl-pyrrocidine B
|
| Molecular Formula | C32H41NO4 | |
| IUPAC Name* |
13-ethenyl-19-methoxy-5,7,9,11-tetramethyl-2-oxa-18-azahexacyclo[19.2.2.13,10.116,19.04,9.014,27]heptacosa-1(23),11,21,24-tetraene-15,17-dione
|
|
| SMILES |
C=CC1C=C(C)C2C3C(Oc4ccc(cc4)CC4(OC)CC(C(=O)N4)C(=O)C13)C1C(C)CC(C)CC21C
|
|
| InChI |
InChI=1S/C32H41NO4/c1-7-21-13-19(4)26-25-24(21)28(34)23-16-32(36-6,33-30(23)35)15-20-8-10-22(11-9-20)37-29(25)27-18(3)12-17(2)14-31(26,27)5/h7-11,13,17-18,21,23-27,29H,1,12,14-16H2,2-6H3,(H,33,35)/t17-,18+,21-,23+,24+,25-,26+,27+,29+,31+,32-/m1/s1
|
|
| InChIKey |
XBLFMZZPVMKTQU-KEZDDGMYSA-N
|
|
| Synonyms |
NA
|
|
| CAS | NA | |
| PubChem CID | NA | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 503.68 | ALogp: | 5.4 |
| HBD: | 1 | HBA: | 4 |
| Rotatable Bonds: | 2 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 64.6 | Aromatic Rings: | 7 |
| Heavy Atoms: | 37 | QED Weighted: | 0.422 |
| Caco-2 Permeability: | -4.717 | MDCK Permeability: | 0.00009720 |
| Pgp-inhibitor: | 0.93 | Pgp-substrate: | 0.004 |
| Human Intestinal Absorption (HIA): | 0.048 | 20% Bioavailability (F20%): | 0.033 |
| 30% Bioavailability (F30%): | 0.041 |
| Blood-Brain-Barrier Penetration (BBB): | 0.234 | Plasma Protein Binding (PPB): | 98.29% |
| Volume Distribution (VD): | 1.808 | Fu: | 1.61% |
| CYP1A2-inhibitor: | 0.036 | CYP1A2-substrate: | 0.919 |
| CYP2C19-inhibitor: | 0.625 | CYP2C19-substrate: | 0.941 |
| CYP2C9-inhibitor: | 0.469 | CYP2C9-substrate: | 0.101 |
| CYP2D6-inhibitor: | 0.057 | CYP2D6-substrate: | 0.672 |
| CYP3A4-inhibitor: | 0.908 | CYP3A4-substrate: | 0.891 |
| Clearance (CL): | 13.609 | Half-life (T1/2): | 0.018 |
| hERG Blockers: | 0.412 | Human Hepatotoxicity (H-HT): | 0.659 |
| Drug-inuced Liver Injury (DILI): | 0.926 | AMES Toxicity: | 0.03 |
| Rat Oral Acute Toxicity: | 0.997 | Maximum Recommended Daily Dose: | 0.943 |
| Skin Sensitization: | 0.025 | Carcinogencity: | 0.027 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.006 |
| Respiratory Toxicity: | 0.93 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC003349 | ![]() |
0.845 | D0VA0I | ![]() |
0.219 | ||
| ENC003137 | ![]() |
0.692 | D0W2EK | ![]() |
0.216 | ||
| ENC004853 | ![]() |
0.667 | D07DIM | ![]() |
0.210 | ||
| ENC004852 | ![]() |
0.617 | D0TG7I | ![]() |
0.208 | ||
| ENC003503 | ![]() |
0.577 | D0V4WD | ![]() |
0.208 | ||
| ENC003989 | ![]() |
0.564 | D09HNR | ![]() |
0.203 | ||
| ENC003851 | ![]() |
0.552 | D0E9KA | ![]() |
0.201 | ||
| ENC005770 | ![]() |
0.543 | D0H0ND | ![]() |
0.201 | ||
| ENC005768 | ![]() |
0.515 | D09WYX | ![]() |
0.201 | ||
| ENC005769 | ![]() |
0.453 | D06OMK | ![]() |
0.200 | ||